NEWS
Making it easy for our investors to stay current with our portfolio companies and their industries.
May 13, 2025
Intensity Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
May 13, 2025
GE HealthCare and Raydiant Oximetry accelerate innovation in fetal oxygen saturation technology
May 6, 2025
Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Receive European Medicines Agency Authorization to Initiate Phase 2 INVINCIBLE-4 (SAKK/66/22) Study for INT230-6 in the Treatment of Presurgical Triple-Negative Breast Cancer in France
April 28, 2025
Meet the companies racing to build quantum chips
April 26, 2025
Ocient Completes $132M Series B Round, Hires New CFO